Bioniq Raises $15M Series B Funding to Expand AI-Driven Personalized Supplement Offerings
Tuesday, 16 July 2024, 13:06
Bioniq Secures $15M Series B Funding Round
Bioniq, a pioneering leader in AI-driven personalized supplements, has successfully raised $15 million in Series B funding. This strategic investment will fuel the expansion of Bioniq's innovative product line and enhance its cutting-edge technology platform.
Key Points:
- Bioniq raises $15 million in Series B funding round
- Focus on AI-driven personalized supplements
- Expansion of product line and technology platform
The funding round was led by tech-driven AI supplement pioneer Bioniq, solidifying its position as a frontrunner in the rapidly evolving health and wellness market.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.